Bapineuzumab for mild to moderate Alzheimer’s disease in two global, randomized, phase 3 trials

被引：0

作者：

Rik Vandenberghe

Juha O. Rinne

Mercè Boada

Sadao Katayama

Philip Scheltens

Bruno Vellas

Michael Tuchman

Achim Gass

Jochen B. Fiebach

Derek Hill

Kasia Lobello

David Li

Tom McRae

Prisca Lucas

Iona Evans

Kevin Booth

Gerald Luscan

Bradley T. Wyman

Lisa Hua

Lingfeng Yang

H. Robert Brashear

Ronald S. Black

机构：

[1] Alzheimer Research Centre KU Leuven,University Hospitals Leuven, Department of Neurosciences

[2] University of Turku and Turku University Hospital,Turku PET Centre and Division of Clinical Neurosciences

[3] Fundació ACE,Graduate School of Biomedical Sciences

[4] Barcelona Alzheimer Treatment and Research Center,Alzheimercentrum VUmc, Neurology

[5] Hiroshima University,Department of Neurology, University Hospital Mannheim

[6] VU University Medical Center,undefined

[7] CHU Toulouse,undefined

[8] Gérontopôle,undefined

[9] Palm Beach Neurological Center,undefined

[10] University Medical Centre Mannheim,undefined

[11] Center for Stroke Research Berlin (CSB),undefined

[12] Charité Universitätsmedizin Berlin,undefined

[13] IXICO Ltd.,undefined

[14] The London Bioscience Innovation Centre,undefined

[15] Pfizer Inc.,undefined

[16] Pfizer Inc.,undefined

[17] Pfizer Global Research and Development (PGRD),undefined

[18] Pfizer Ltd.,undefined

[19] Pfizer Inc.,undefined

[20] Janssen Alzheimer Immunotherapy Research & Development,undefined

[21] LLC,undefined

来源：

Alzheimer's Research & Therapy | / 8卷

关键词：

Alzheimer’s disease; Bapineuzumab; Immunotherapy; Amyloid β; Clinical trial; ARIA-E; Vasogenic edema;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[31] Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer's Disease [J].

Huell, Michael ;

Sadowsky, Carl ;

Arai, Heii ;

Leterme, Ghislaine Le Prince ;

Holstein, Ann ;

Booth, Kevin ;

Peng, Yahong ;

Yoshiyama, Tamotsu ;

Suzuki, Hideo ;

Ketter, Nzeera ;

Liu, Enchi ;

Ryan, J. Michael .

CURRENT ALZHEIMER RESEARCH, 2017, 14 (07) :696-708

[32] Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial [J].

Dubois, Bruno ;

Lopez-Arrieta, Jesus ;

Lipschitz, Stanley ;

Triantafyllos, Doskas ;

Spiru, Luiza ;

Moroz, Svitlana ;

Venger, Olena ;

Vermersch, Patrick ;

Moussy, Alain ;

Mansfield, Colin D. D. ;

Hermine, Olivier ;

Tsolaki, Magda .

ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)

[33] Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial [J].

Bruno Dubois ;

Jesús López-Arrieta ;

Stanley Lipschitz ;

Triantafyllos Doskas ;

Luiza Spiru ;

Svitlana Moroz ;

Olena Venger ;

Patrick Vermersch ;

Alain Moussy ;

Colin D. Mansfield ;

Olivier Hermine ;

Magda Tsolaki .

Alzheimer's Research & Therapy, 15

[34] Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease [J].

Samantha Budd Haeberlein ;

P.S. Aisen ;

F. Barkhof ;

S. Chalkias ;

T. Chen ;

S. Cohen ;

G. Dent ;

O. Hansson ;

K. Harrison ;

C. von Hehn ;

T. Iwatsubo ;

C. Mallinckrodt ;

C.J. Mummery ;

K.K. Muralidharan ;

I. Nestorov ;

L. Nisenbaum ;

R. Rajagovindan ;

L. Skordos ;

Y. Tian ;

C.H. van Dyck ;

B. Vellas ;

S. Wu ;

Y. Zhu ;

A. Sandrock .

The Journal of Prevention of Alzheimer's Disease, 2022, 9 (2) :197-210

[35] Two Phase 2 Multiple Ascending-Dose Studies of Vanutide Cridificar (ACC-001) and QS-21 Adjuvant in Mild-to-Moderate Alzheimer's Disease [J].

Pasquier, Florence ;

Sadowsky, Carl ;

Holstein, Ann ;

Leterme, Ghislaine Le Prince ;

Peng, Yahong ;

Jackson, Nicholas ;

Fox, Nick C. ;

Ketter, Nzeera ;

Liu, Enchi ;

Ryan, J. Michael .

JOURNAL OF ALZHEIMERS DISEASE, 2016, 51 (04) :1131-1143

[36] Heterogeneity in Cost-Effectiveness Analysis of Vaccination for Mild and Moderate Alzheimer's Disease [J].

Lin, Chung-Hsien ;

Fann, Jean Ching-Yuan ;

Chen, Sam Li-Sheng ;

Chen, Hsiu-Hsi ;

Yang, Kuen-Cheh .

CURRENT ALZHEIMER RESEARCH, 2019, 16 (06) :495-504

[37] Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer's Disease [J].

Yang, Kuen-Cheh ;

Chen, Hsiu-Hsi .

CURRENT ALZHEIMER RESEARCH, 2016, 13 (07) :809-816

[38] Sleep disturbance in mild to moderate Alzheimer's disease [J].

Moran, M ;

Lynch, CA ;

Walsh, C ;

Coen, R ;

Coakley, D ;

Lawlor, BA .

SLEEP MEDICINE, 2005, 6 (04) :347-352

[39] Management of mild to moderate Alzheimer's disease and dementia [J].

Hogan, David B. ;

Bailey, Peter ;

Carswell, Anne ;

Clarke, Barry ;

Cohen, Carole ;

Forbes, Dorothy ;

Man-Son-Hing, Malcolm ;

Lanctot, Krista ;

Morgan, Debra ;

Thorpe, Lilian .

ALZHEIMERS & DEMENTIA, 2007, 3 (04) :355-384

[40] Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial [J].

Howard, Robert ;

Cort, Elizabeth ;

Rawlinson, Charlotte ;

Wiegand, Martin ;

Downey, Anne ;

Lawrence, Vanessa ;

Banerjee, Sube ;

Bentham, Peter ;

Fox, Chris ;

Harwood, Rowan ;

Hunter, Rachel ;

Livingston, Gill ;

Moniz-Cook, Esme ;

Panca, Monica ;

Raczek, Malgorzata ;

Ivenso, Chineze ;

Russell, Gregor ;

Thomas, Alan ;

Wilkinson, Philip ;

Freemantle, Nicholas ;

Gould, Rebecca .

ALZHEIMERS & DEMENTIA, 2024, 20 (04) :2990-2999

← 1 2 3 4 5 →